Results 281 to 290 of about 67,507 (290)
Some of the next articles are maybe not open access.

Enzalutamide in Castration-Resistant Prostate Cancer

New England Journal of Medicine, 2018
Giacomo, Bregni   +2 more
openaire   +4 more sources

[Castration resistant prostate cancer 2011].

Aktuelle Urologie, 2011
Our understanding of - as well as our approach to - castration resistant prostate cancer is currently undergoing major changes. New drugs like the CYP-17 inhibitor abiraterone have shown that even in the "hormone refractory" stage the progression of prostate cancer is still driven by signaling of the androgen receptor.
openaire   +1 more source

Denosumab in castration-resistant prostate cancer

The Lancet, 2012
Athanassios, Kyrgidis   +1 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy